Human prostate tumors express CX3CR1, which facilitates their adhesion to bone marrow CX3CL1-expressing endothelial cells as well as osteoblasts, and triggers PI3K/AKT pathway activation [233]. Here, CX3CR1 is linked to prostate neoplasm.